Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.32 HKD | -2.92% | -0.64% | +64.96% |
May. 03 | Dongyue Group Says Chairman, Shareholder Qixin Investment Terminate Voting-Alignment Agreement | MT |
Mar. 27 | Dongyue Group's Attributable Profit Plunges as Revenue Declines | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 65% by 2026.
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The company is in a robust financial situation considering its net cash and margin position.
- The company's attractive earnings multiples are brought to light by a P/E ratio at 10.73 for the current year.
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.66 for the 2024 fiscal year.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+64.96% | 2.07B | C | ||
+17.07% | 66.31B | A- | ||
-0.29% | 48.46B | A- | ||
+21.61% | 43.27B | B+ | ||
+26.72% | 27.41B | A- | ||
+9.25% | 19.26B | C+ | ||
+9.75% | 16.58B | B+ | ||
-2.14% | 16.61B | B+ | ||
-15.01% | 14.41B | C+ | ||
-30.22% | 14.02B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 189 Stock
- Ratings Dongyue Group Limited